Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
315.12
+0.58 (+0.18%)
Streaming Delayed Price
Updated: 10:15 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
Check Out What Whales Are Doing With AMGN
December 16, 2021
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
2 Top Dividend Stocks That Just Hiked Their Payouts by 10% or More
December 13, 2021
And there could be even more increases in the future.
Via
The Motley Fool
5 Dividend Growth Stocks Getting Crushed… Time To Buy?
December 11, 2021
We have a disconnect between business performance and stock performance. And we have a disconnect between individual stocks and the stock market. These disconnects could lead us to fantastic long-term...
Via
Talk Markets
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
December 07, 2021
Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...
Via
Benzinga
Analyst Ratings For Amgen
November 19, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:
Via
Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
December 07, 2021
Can-Fite BioPharma Ltd (NYSE: CANF) announced that the last of approximately 400 psoriasis patients enrolled in its Phase 3 Comfort study is scheduled to complete a 16-week...
Via
Benzinga
What 8 Analyst Ratings Have To Say About Amgen
December 06, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:
Via
Benzinga
Time To Load Up? This Dividend Growth Stock Has Been Beat Down By 30%
December 06, 2021
Amgen is benefiting from a rising tide that is lifting all boats. Already, Amgen has increased its dividend for 11 consecutive years.
Via
Talk Markets
A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Up 2%
December 06, 2021
Pre-open movers U.S. stock futures traded mostly higher in early pre-market trade after the Nasdaq dropped close to 300 points in the previous session. Investors are awaiting...
Via
Benzinga
Exposures
Fossil Fuels
5 Stocks To Watch For December 6, 2021
December 06, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Science Applications International Corporation (NYSE: SAIC) to report quarterly earnings at $1.50...
Via
Benzinga
4 Top Nasdaq-100 Stocks To Buy In December
December 04, 2021
The tech-heavy Nasdaq 100 trended higher this week amid the uncertainties surrounding inflation and the emergence of the Omicron coronavirus variant. So, we believe these fundamentally sound Nasdaq 100...
Via
Talk Markets
Exposures
COVID-19
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-...
Via
Benzinga
Exposures
COVID-19
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
December 02, 2021
Johnson & Johnson's (NYSE: JNJ) Janssen Biotech Inc has received FDA approval for Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with...
Via
Benzinga
Exposures
Product Safety
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
December 02, 2021
Amgen Inc (NASDAQ: AMGN) announced topline results from the DISCREET trial Phase 3 trial of Otezla (apremilast) in adults with moderate to severe genital psoriasis...
Via
Benzinga
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
Via
InvestorPlace
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Amgen: For Growth And Income Investors
November 29, 2021
Amgen focuses on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation.
Via
Talk Markets
Price Over Earnings Overview: Amgen
November 29, 2021
In the current market session, Amgen Inc. (NASDAQ:AMGN) is trading at $202.59, after a 0.75% gain. However, over the past month, the stock fell by 5.41%, and in the...
Via
Benzinga
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
November 29, 2021
The FDA has accepted for review Bristol Myers Squibb & Co's (NYSE: BMY) deucravacitinib for the treatment of adults with moderate to severe plaque psoriasis...
Via
Benzinga
Exposures
Product Safety
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
November 28, 2021
Affimed, Amgen, and Bristol Myers Squibb are too cheap to ignore right now.
Via
The Motley Fool
Exposures
COVID-19
Should You Buy This Giant Biotech Stock?
November 26, 2021
Amgen beat analysts' earnings expectations in the third quarter, and its balance sheet remains admirable.
Via
The Motley Fool
10 Biggest Price Target Changes For Monday
November 22, 2021
MKM Partners cut Activision Blizzard, Inc. (NASDAQ:A...
Via
Benzinga
2 Dividend Stocks to Buy Right Now
November 19, 2021
These two drugmakers have a solid track record.
Via
The Motley Fool
3 Pharma Stocks That Could Make You Richer in November (and Beyond)
November 12, 2021
Two of them have already been big winners for investors this year.
Via
The Motley Fool
Here Are the Highlights From Amgen's Q3 Results
November 11, 2021
The big biotech reported only modest sales growth.
Via
The Motley Fool
3 Nasdaq Stocks to Buy and Hold for Years
November 10, 2021
Many companies are showing strong continued growth, but investors should focus on stocks to buy with the best long-term prospects.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:
Via
Benzinga
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.